Peptide Cycling Protocols: How Long to Run Each Peptide and When to Take a Break
Evidence-based cycling schedules for BPC-157, TB-500, CJC-1295/Ipamorelin, Sermorelin, Epithalon, and Thymosin Alpha-1 — when to run, when to pause, and why it matters.
Peptide Therapy
Limited EvidenceSynthetic tetrapeptide studied mainly in lab and animal work; no independent human trials. What the evidence shows.
Evidence-based cycling schedules for BPC-157, TB-500, CJC-1295/Ipamorelin, Sermorelin, Epithalon, and Thymosin Alpha-1 — when to run, when to pause, and why it matters.
Epithalon vs NMN comparison by Dr. med. univ. Julian Douwes. Telomere lengthening vs NAD+ replenishment — different aging hallmarks, different evidence, and when to use each.
Evidence-based Epithalon dosing guide. Injection protocols, 10-20 day cycling, annual scheduling, and telomere monitoring from Dr. med. univ. Julian Douwes.
Epithalon peptide review by Dr. med. univ. Julian Douwes. Telomerase activation, longevity research, limited human data, and the telomere-cancer question examined honestly